Estrogen stimulates breast development during puberty and mammary tumors in adulthood through estrogen receptor-a (ERa hi MaSC population that may be responsible for the hormonal sensitivity of the developing mammary gland.
SUMMARY
Estrogen stimulates breast development during puberty and mammary tumors in adulthood through estrogen receptor-a (ERa MaSCs. We show that the MaSC population has a distinct SCA-1 + population that is abundant in pre-pubertal mammary glands.
The SCA-1 + MaSCs have less stem cell markers and less in vivo repopulating activity than their SCA-1 neg counterparts. However, they express ERa and specifically enter the cell cycle at puberty. Using estrogen-deficient aromatase knockouts (ArKO), we showed that the SCA-1 + MaSC could be directly modulated by estrogen supplementation. Thus, SCA-1 enriches for an ERa + , estrogen-sensitive subpopulation within the CD24 + /CD49f
hi MaSC population that may be responsible for the hormonal sensitivity of the developing mammary gland.
INTRODUCTION
Estrogen exposure has long been associated with breast cancer (BCa) risk and early-life estrogen exposures can have impacts many decades later (Warri et al., 2008; Clemons and Goss, 2001) . Estrogen is also important for normal mammary gland development, with aromatase knockout (ArKO) and estrogen receptor-a (ERa)-deficient mice showing only rudimentary ductal structures (Fisher et al., 1998; Hewitt et al., 2010) . It was therefore surprising to find that adult mouse mammary epithelial cells enriched for mammary stem cell (MaSC) activity (CD24 + CD29 hi / CD24 + CD49f hi ) were ERa negative . However, MaSCs are extremely sensitive to estrogens and progesterone, as evidenced by their loss with ovariectomy and their increase during pregnancy (Asselin-Labat et al., 2010) . It is now accepted that MaSC hormone sensitivity is mediated indirectly by the RANK/ RANKL axis (Asselin-Labat et al., 2010; Joshi et al., 2010; Tanos et al., 2013) . Stem cell activity within the mammary gland was first described using mammary fat pad transplants (Daniel et al., 1968; Deome et al., 1959) . Several investigators then used morphology to define these cells in tissue sections by nature of their small light appearance at the ultrastructural level, or by their localization within the cap cells of terminal end buds (TEBs) (Chepko and Smith, 1997; Williams and Daniel, 1983) . More recent research has focused on trying to determine the identity of MaSCs using cell surface markers. Stem cell antigen 1 (SCA-1) had been used to isolate hematopoietic stem cells (HSCs) (Goodell et al., 1996; Spangrude et al., 1988) , and Welm et al. (2002) assessed SCA-1 expression in the mammary gland. They showed SCA-1 was highest in the mammary populations that possessed in vivo stem cell activity. Following this study, a combination of cell surface markers, also adapted from the hematopoietic system, were used to enrich for MaSCs, including heat stable antigen CD24 and either integrin beta-1 (CD29) or integrin alpha 6 (CD49f) or SCA-l negativity Sleeman et al., 2007) . These markers led to a disagreement with the findings of Welm et al. (2002) and the role of SCA-1 in MaSC isolation has remained controversial.
Most recently, SCA-1 has been used to define ERa Figure 1C ). The CD24 + CD49f hi SCA-1 + subset was highly abundant in young mice and decreased with age ( Figure 1D ). The CD24 + CD49f hi SCA-1 neg population followed the same trend as the parent CD24 + CD49f hi population ( Figure 1E ).
To ensure that the SCA-1 + subset of CD24 + CD49f hi cells
was not contaminating SCA-1 + luminal cells, we assessed epithelial lineages in Ly6A (SCA-1)-GFP mice (Alvi et al., 2003) . Using EpCAM and CD49f, which has recently been shown to give similar results to CD24 and CD49f (Shehata et al., 2012) Bouras et al., 2008; Kendrick et al., 2008; Cheng et al., 2000) . These included Lgr5 (a Wnt regulated target gene), a-SMA (a cytoskeletal protein in basal cells, within which the stem cell population resides), Id4 (inhibitor of DNA binding 4 that maintains the stem cell pool), p63 (a p53 gene family member that regulates epithelial proliferation and differentiation), Delta1, Fzd7, and Jag1 (notch receptor ligands). Jag1 has been identified within MaSC Kendrick et al., 2008; Cheng et al., 2000) and luminal cells (Bouras et al., 2008) . We assessed Hes1, which plays an important role in the Notch signaling pathway (Kageyama and Ohtsuka, 1999) and Mef2c, a transcription factor that regulates cell fate decisions and is present in human and mouse MaSC (Cheng et al., 2000) and long-term HSC (LTHSCs) (Ficara et al., 2008) . Also included was Aldh1a1 (a detoxifying enzyme responsible for the oxidation of intracellular aldehydes) since it has been used as a BCa stem cell (CSC) marker and is present in SCA-1 + CSC. We also assessed the levels of luminal markers Keratin18, Notch1, Hey 1, and Hey 2 and the luminal progenitor markers Elf5 and C-kit to determine if the SCA-1 + cells were progenitors rather than stem cells per se. Finally, we assessed the levels of the cell-cycle-related genes Cyclin D1 and Cyclin D2, which have been associated with luminal and basal cell populations, respectively (Joshi et al., 2010 As the SCA-1 + subset of cells is abundant in the pre-pubertal mammary gland and declines when estrogen-driven mammary growth occurs, we reasoned these cells may represent a quiescent stem cell pool. To investigate, this cell-cycle activity was analyzed using Ki67 and Hoechst 33342 in 3-and 6-week-old FVB/n mice (Cheng et al., 2000; Mullally et al., 2013) . As expected at 3 weeks of age, prior to the onset of ductal growth in the mammary gland, the total CD24 + CD49f hi MaSC population was predominantly in G 0 of the cell cycle ( Figure 4A ). The G 0 and G 1 gates were set using fluorescence minus one (FMO) controls lacking Ki67 ( Figure S5 ). The luminal and nonepithelial populations were also predominantly quiescent at this age (data not shown). population was predominantly arrested in the G 1 checkpoint, with a small percentage in G 2 /S/M stages ( Figure 4B ). In contrast, the CD24 + CD49f hi SCA-1 + cells were predominantly cycling ( Figure 4C ). Average values for three biological replicate pools of 20 animals are shown for 3 weeks ( Figure 4D ) and 6 weeks ( Figure 4E ). Together, these data indicate that SCA-1 does not enrich for a quiescent population of cells within the CD24 + CD49f hi population but instead enriches for a population of cells that is specifically activated to enter into the cell cycle at puberty.
TEBs Are Enriched for SCA-1 + Cells
To assess whether this specific activation of mitotic activity in SCA-1 + subset was due to their involvement of TEB proliferation, the proportion of CD24 + CD49f hi SCA-1 + and SCA-1 neg cells in TEBs was assessed ( Figure 5 ). Using a gentle dissociation, TEBs were specifically isolated (Figure 5A) and enzymatically digested to single cells and analyzed by flow cytometry ( Figure 5B ). Ducts were isolated and processed in a similar manner for comparison (Figure 5C) , as were the TEB and duct-depleted samples (Figure 5D ). Within the CD49f hi population, there was a higher proportion of SCA-1 + cells in the TEB (80%) compared with the DUCT (10.53%) and TEB and DUCT-depleted (17.77%) samples . Consistent with these findings, analysis of the RNAs from isolated TEBs and ducts showed that the TEBs were enriched for cell-cycle pathways (Table  S1 ) (Morris et al., 2006) .
MaSCs have been shown previously to be ERa neg (AsselinLabat et al., 2006; Sleeman et al., 2007) , and yet we observed a specific activation of mitotic activity in the CD24 + CD49f hi SCA-1 + cells at puberty. We reasoned they may be responding to the hormonal surge at puberty and assessed the expression of hormone receptors. ERa mRNA levels and its target gene progesterone receptor (PR) were assessed using qPCR in three biological pools of 20 mice each. As anticipated, ERa was highest in the SCA-1 + luminal cells and absent in the CD24 + CD49f hi SCA-1 neg MaSC population ( Figure 6A ) (Sleeman et al., 2007; Asselin-Labat et al., 2006) . The CD24 + CD49f hi SCA-1 + cells had 20-fold higher levels of ERa at 3 weeks and 5-fold higher levels at 6 weeks compared with CD24 + CD49f hi SCA-1 neg cells ( Figure 6A ). We also assessed the levels of Egfr and Rank/Rankl, as these have been proposed to mediate hormone action in MaSCs (Asselin-Labat et al., 2010 Figure 6F ). Rankl and Rank receptor (Tnfrsf11a) are reported to be expressed in the luminal and MaSC populations, respectively (Asselin-Labat et al., 2010). In our study, Rankl was absent at 3 weeks of age and present only in the luminal cells at (ERE). We analyzed the mRNA sequence using both the dragon ERE program and mined the existing data from a genome-wide screen for high-affinity ERE in the mouse and human genomes (Bourdeau et al., 2004) . The latter study used stringent cutoffs of two base deviations from consensus, also a location of the ERE within À10 to +5 kb of the transcriptional start site. The data were complementary. As shown in Figure 6G , EREs were not found within the genes Aldh1, a-SMA, Delta1, Id4, Hes1, or Lgr5, all of which were highly expressed in the CD24 + CD49f hi SCA- (Figures 7D-7F) . Similarly, the CD24 + CD49f hi MaSC populations from ERa AF2 region mutated mice (AF2ERKI) ( Figure 7G ) and from the aromatase-deficient mice (ArKO) ( Figure 7H ), which each have only a rudimentary ductal gland phenotype, also possessed largely CD24 + CD49f hi SCA-1 + cells. This is summarized in Figure 7I . To see if the CD24 + CD49f hi SCA-1 + cells were estrogen sensitive, we treated ArKO mice with 17b-estradiol pellets from post-natal day (P) 5 for 6 weeks. The 17b-estradiol supplementation led to increased mammary ductal growth in the ArKO mice ( Figure 7J ) and resulted in a reduction in the number of the CD24 + CD49f hi SCA-1 + cells from 92% in placebo-treated ArKO mice to an average of 49% ( Figure 7K ). To complement these results, adult (8-weekold) wild-type C57BL/6 mice were treated with the ER antagonist tamoxifen (n = 5/group). At 12 weeks, the proportion of CD24 + CD49f hi SCA-1 + cells was significantly increased in tamoxifen-treated versus control mice (p = 0.0036; Figure S6 ).
DISCUSSION
SCA-1 positivity identifies normal stem cells in many organs, cancer stem cells in the breast (Burger et al., 2005; Matsuura et al., 2004; Spangrude, 1989; Jo et al., 2009) , and LT-HSCs in blood (Osawa et al., 1996; Zhao et al., 2000) , yet its usefulness in isolating mouse MaSCs remains controversial. Here, we found that SCA-1 could identify a population within the CD24 + /EpCAM + /CD49f hi MaSC-enriched population that had less repopulating activity than the SCA-1 neg counterparts but was ERa + and estrogen responsive. This ERa + population of MaSCs was abundant in young, but not old, mammary glands and was responsive to endogenous and exogenous estrogens. The results of this study show the SCA-1 + subset of the CD24 + CD49f hi population is highest in young mice and (Bai and Rohrschneider, 2010) are at their highest density in the mammary glands of young mice (Russo and Russo, 1978a; Russo et al., 1982) . In this study, we have further challenged this theory by showing that MaSCs are not enriched within the TEBs, with a small proportion also found in the ducts of the mammary gland. The reason for an increase in CD24 + CD49f hi cell numbers with age requires additional investigation, but is consistent with emerging data showing that MaSCs are increased in older animals (Huh et al., 2015; Plaks et al., 2013 of Notch receptor ligands and target genes (Jagged 1, Hes1, Hey 1, Hey2), which are all more associated with differentiated cells in the breast, but Hes1 has also been linked to LTHSCs. Mef2c is a transcription factor with identified roles in cardiac morphogenesis and myogenesis. It is present in human and mouse MaSCs (Cheng et al., 2000) and is also present in LT-HSCs (Ficara et al., 2008) limited (in vitro mammospheres and in vivo transplants), they were able to generate all the lineages, thereby fulfilling a major requirement of an MaSC. However, they did not have progenitor activity in vitro. Our data showing that the SCA-1 neg compartment has higher in vivo stem cell activity is consistent with the work of Stingl et al. (2006) and Shackleton et al. (2006) but contrasts with the work of Welm et al. (2002) , who showed SCA-1 enriched for MaSCs. However, these early studies compared the SCA-1 + versus negative epithelial cell compartments without prior selection on lineage or epithelial cells and so may be complicated by the inclusion of nonepithelial cells. They were unable to calculate the stem cell enrichment, as only six transplants were completed and the cell inoculum varied. Direct comparisons in the same laboratory with numerous replicates at each dose are required to determine why these differences occur.
In line with the aforementioned hypothesis that changes with the SCA-1 + subset of the CD24 + CD49f hi population with age is in response to estrogen signaling, we showed that the CD24 + CD49f hi SCA-1 + cells are mitotically active Sleeman et al., 2007) . We propose this was a consequence of using 10-to 12-week-old mice, in which the CD24 + CD49f hi SCA-1 + subset is quite low. However, Asselin-Labat et al. (2006) did report that 0.01% of the MaSC cells that they assessed had ERa expression, and thus it may be that these rare cells were the SCA-1 + cells in the MaSC pool.
As the CD24 + CD49f hi SCA-1 + cells decrease at puberty but paradoxically express ERa, it was proposed that they were negatively regulated by estrogen. This was confirmed when estrogen-deficient mouse models (Ex3aERKO, AF2ERKI, and ArKO) were assessed as adults (10-12 weeks of age) and showed a high proportion of CD24 + CD49f Nakada et al. (2014) recently proved could be mediated by estrogen. Estrogen was also shown to be critical for the mobilization of proliferating HSCs to the spleen and expansion of splenic erythropoiesis during pregnancy (Nakada et al., 2014) . In line with their estrogen responsiveness and activation of the cell cycle at puberty, the CD24 + CD49f hi SCA-1 + cells
were found to be enriched in TEBs. TEBs are highest in the pubertal animal and are considered the proliferative unit of the developing gland (Russo and Russo, 1978a , 1978b , 1980 . This agrees with our data showing that the SCA-1 + TEBS are abundant and actively cycling at puberty. TEBs have been associated with the carcinogen sensitivity of the mammary gland, yet whether the stem cells or the proliferative nature of the TEBs is responsible is unclear (Russo et al., 1979 
EXPERIMENTAL PROCEDURES

Animals and Breeding Experiments
Animal experiments were completed under approval from Monash University Animal Ethics Committee, Peter MacCallum Cancer Centre Animal Ethics Committee, Animal Ethics Committee of Florey Institute or under the UK Animals Scientific Procedures Act 1986. MaSCs were isolated from fourth mammary fat pads of FVB/n mice at 3, 6, 9, and 25 weeks of age for the age, transplant, and qPCR experiments.
LGR5-GFP mice (B6.129P2-Lgr5tm1 (cre/ ERT2)Cle/J) were a kind gift from Hans Clevers (Barker et al., 2007) . ERa knockout (Ex3aERKO), ERa AF2 domain dysfunctional (AF2ERKI) (Arao et al., 2011) , aromatase-deficient (ArKO) (Fisher et al., 1998) , and Ly-6A (SCA-1) GFP transgenic mice (Alvi et al., 2003) have all been described before. All mice were housed under specific pathogen-free conditions. ER-and aromatase-deficient mice were maintained on a soy-free diet (Specialty Feeds), with undetectable levels of isoflavones (Soyfree), as dietary phytoestrogens have been shown to be estrogenic in estrogen-deficient mice (Britt et al., 2002) .
Isolation, Staining, and Flow Cytometric Analysis of Mouse Mammary Cells
MaSCs were isolated using mechanical and enzymatic digestion followed by fluorescence-activated cell sorting (FACS), as detailed previously Sleeman et al., 2007 
Isolation of Mammary TEBs and Ducts
TEB and duct isolation was performed as previously (Morris et al., 2004) with modifications. Mammary glands were collected from FVB/n mice at 5-6 weeks of age and coarsely chopped in a Petri dish using scalpel blades before incubation in digest mixture (1 mg/mL collagenase 1 [Worthington] in 10 mL of serum-free L15) at 37 C for 25 min. Following this, the tube was vigorously shaken, and the digest mix was split into two 50 mL Falcon tubes. Tubes were made up to 50 mL with serum containing L15. The tubes were then briefly centrifuged, and the pellets from each tube were combined and centrifuged again before placing onto a gridded 35 mm Petri dish (Thermo Scientific) under a dissecting microscope. Using a 10 mL pipette set to 2 mL, TEBs and ducts were gently sucked up the pipette tip and placed into serum containing L15. Within an hour, TEB and ducts were gently trypsinized to obtain single cells and stained for flow cytometry.
Limiting Dilution Fat Pad Transplantation Assays and Outgrowth Confirmation
MaSCs were isolated from 6-week-old nulliparous animals for comparison of the CD24 + CD49f hi SCA-1 neg and CD24 + CD49f hi SCA-1 + populations. MaSCs were collected into serum containing L15 medium (Invitrogen) and immediately resuspended in serum-free L15 at the required concentration. Fresh cells were transplanted into cleared fat pads of 3-week-old mice as described previously (Britt et al., 2009) . After 10 weeks, the reconstituted fat pads were removed and assessed by carmine-stained wholemounts. All outgrowths were dissected and processed into paraffin blocks for confirmation of structure and cell lineage analysis by immunohistochemistry. Keratin 14/18 dual immunofluorescence was completed as described previously (Britt et al., 2009 ). All sections were examined on a Nikon C1 confocal microscope, Invert, based on Nikon Eclipse Ti and captured using the NIS Elements Nikon acquisition software. Single antibody-stained control sections, where either the primary antibody was absent or was combined with an inappropriate secondary antibody, were used to confirm the specific staining. ERa staining was completed as described previously (Britt et al., 2009 ). The MaSC enrichment within each population was determined using the extreme limiting dilution statistical analysis program (Hu and Smyth, 2009 ).
Cell-Cycle Analysis Using Hoechst 33342 and Ki67
To distinguish cells in G 0 /G 1 from cells in G 2 /S/M, the samples were stained with the DNA binding dye Hoechst 33342 and Ki67 to delineate G 0 from G 1 since Ki67 is not present in noncycling (G 0 ) cells (Mullally et al., 2013) . All cells were immunostained for lineage markers mentioned above before fixing and permeabilizing with a Fix and Perm Kit (Invitrogen). Simultaneous staining of Ki67 (clone B56, catalog no 556003; BD Biosciences) 1:20 in reagent B of the Fix and Perm Kit was completed at room temperature for 30 min. Cells were washed in PBS/0.1% NaN 3 /5% fetal bovine serum (FBS), spun down at 3500 3 g for 5 min, and resuspended pellet in Hank's balanced salt solution with 20 mM HEPES, 10% FBS, 1 mg/mL glucose, and 6.16 mg/mL Hoechst 33342 (catalog no. H1399; Molecular Probes) and incubated for 30 min at room temperature. Finally, the cells were washed and resuspended in Lebovitz's/10% FBS and analyzed by flow cytometry on an LSRIIb (BD Biosciences).
RT-PCR Analysis
RNA was isolated from flow-cytometry-sorted cell populations using the RNeasy Micro Kit (QIAGEN) following the manufacturer's instructions. RNA content was quantitated using the Qubit 2.0 Fluorometer (Invitrogen) and quality was determined using a 2100 Bioanalyzer (Agilent Technologies). cDNA was synthesized by reverse transcription using Superscript III, random primers, and dNTPs (Invitrogen) and pre-amplified with TaqMan PreAMP master mix (Applied Biosystems) as per the manufacturer's instructions. qRT-PCR was completed using TaqMan probes on a 7900HT Thermocycler (Applied Biosystems) in a reaction consisting of 50 ng of cDNA, 0.5 mL of TaqMan probe, 5 mL of TaqMan Advance Mastermix, 3 mL of H 2 O under the following conditions: 50 C for 2 min, 96 C for 20 s, 95 C for 1 s, and 60 C for 20 s, with 40 cycles of the last two conditions. The data were analyzed using SDS version 2.3 software. Relative expression of each probe to housekeeping probe 18S in each sample was determined using the 2 DDCT method. Samples were normalized and compared with the 6 week CD24 + CD49f hi SCA-1 neg control. The relative gene expression levels were analyzed using GraphPad Prism. A normality test could not be completed (three biological replicates of n = 20 pooled mice), and thus a nonparametric Kruskal-Wallis test with Dunn's multiple comparison was used. p Values less than 0.05 were considered statistically significant. Table S2 shows the TaqMan primers used for these studies.
ERa Immunofluorescence Staining
FACS-sorted cells were cytospun onto Superfrost Plus glass slides (Menzel-Gläser) at 600 rpm for 3 min using a Shandon Cytospin 3 (Thermo Scientific). The cells were then fixed onto the slides in PBS/4% paraformaldehyde for 10 min at room temperature. Cells were then permeabilized for 2 min in PBS/0.15% Triton-X 100 (Sigma) and blocked O/N in PBS/1% BSA (Amresco) at 4 C. The following day, ERa anti-mouse monoclonal antibody (ID5 clone, catalog no. M7047; Dako) was added at 1:50 in PBS and incubated for 1 hr at room temperature. Cells were then washed in Tris-buffered saline (TBS)/0.1% Tween 20, before secondary antibody (anti-mouse immunoglobulin G1, 555) was added and incubated at room temperature for 1.5 hr. Cells were then washed in TBS/Tween 20 0.1%, counterstained with 5 mg/mL DAPI (3 3 5-min washes), mounted in Vectashield mounting-media (Vectalabs), and cover-slipped for imaging.
Stem Cell Analysis in Estrogen-Deficient Mice
To determine if the CD24 + CD49f hi SCA-1 + cells were estrogen sensitive, we assessed the MaSC populations present in the ERa-deficient Ex3aERKO mice (Hewitt et al., 2010) , in the ERa dysfunctional AF2ERKI mice (mutations in the AF2 activation function domain of ERa) (Arao et al., 2011) , and in estrogen-deficient ArKO mice (Fisher et al., 1998) . ArKO mice and wild-type mice were treated with 0.2 mg of silastic 17b-estradiol or saline placebo pellets implanted into the dorsal flank from P5 to P47.
